Ultomiris Shows Promise in IgA Nephropathy: What t...
Category : Clinical Trial Update 23 April 2026The race to slow kidney disease progression just got more interesting. Ultomiris has delivered posit...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
CRENESSITY Delivers 2-Year Data in CAH: Less Stero...
Category : Clinical Trial Update 23 April 2026For decades, treating congenital adrenal hyperplasia meant a trade-off: control hormones, but accept...
AskBio Advances Parkinson’s Gene Therapy With Comm...
Category : Clinical Trial Update 22 April 2026In gene therapy, science gets the spotlight. But manufacturing decides whether that science actually...
Ractigen’s RAG-17 Shows Early Promise in ALS — Str...
Category : Clinical Trial Update 22 April 2026In neurodegenerative diseases, early data is usually incremental. This one isn’t. Ractigen The...
Dayspring Pharma’s CG2001 Hits Phase II Goals in M...
Category : Clinical Trial Update 22 April 2026Hair loss treatments rarely deliver both speed and strength. This one might be getting closer. Da...
Latest Newsletter Post
-
CRENESSITY Delivers 2-Year Data in..
23 April 2026
-
Ultomiris Shows Promise in IgA Neph..
23 April 2026
-
Dayspring Pharma’s CG2001 Hits Phas..
22 April 2026
-
Ractigen’s RAG-17 Shows Early Promi..
22 April 2026
-
AskBio Advances Parkinson’s Gene Th..
22 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com